Overview
Munich, May 11, 2023 – McDermott Will & Emery advised Cousin Surgery on its acquisition of PlantTec Medical. The acquisition was financed by Turenne Group’s healthcare-focused private equity fund, Capital Santé 2, along with co-investors including Nord Capital Investissement, Sélection & Opportunités (Turenne Group), Dalle & Associés and Altur Investissement, as well as the management.
Cousin Surgery is a French group specialized in implantable medical devices with a longstanding industrial expertise. Today, the company is a recognized as a specialist in implantable textiles and their application to spine and visceral surgery.
PlantTec Medical is the first company in the world to CE-certify a plant-based product for surgery that not only effectively stops surgical bleeding, but also substantially prevents postoperative tissue adhesions. The polysaccharide-based product 4DRYFIELD® has been used more than 350,000 times in surgical procedures. PlantTec Medical’s solutions are currently sold in over 30 countries worldwide.
The McDermott team advising Cousin Surgery was led partners Emmanuelle Trombe, Dr. Stephan Rau and Dr. Björn Biehl and comprised associates Dr. Robert Feind LL.M., Sebastian Gerstner, Dr. Fabian Appadoo and Edouard Becker.
